Renal ischemia: A new perspective  by Brezis, Mayer et al.
Kidney International, Vol. 26 (1984), pp. 375—383
EDITORIAL REVIEW
Renal ischemia: A new perspective
Acute renal failure (ARF) remains a poorly understood
response of the kidney to hypoperfusion secondary to hypoten-
sion, hypovolemia, and dehydration, presumably mediated by
an acute ischemic insult. Few topics have generated so many
conflicting experimental data and such different pathophys-
iological explanations, as reflected by the variety of names
given to the syndrome: traumatic nephrosis, lower nephron
nephrosis, acute tubular necrosis, vasomotor nephropathy,
postischemic acute renal failure, intrinsic reversible renal fail-
ure, and ischemic nephropathy [1—6]. We will review some of
the puzzling paradoxes posed by ARF and propose another way
to look at the problem, in the light of new experimental
information on renal oxygen deprivation.
The first paradox to consider is that ARF is a clinical
syndrome with extremely variable morphological counterparts.
The delay in functional recovery of the kidney from ARF,
typically 1 to 2 weeks, has usually been viewed as evidence for
intrinsic renal damage awaiting cell regeneration, hence the
term acute tubular necrosis. However, the histological cor-
relates of this assumption have been sparse and controversial.
Some studies claim that the histological appearance of the
kidneys observed in patients with ARF is not significantly
different from that of patients without ARF [7]. Others describe
relatively mild damage with patchy tubular necrosis, usually
extremely focal, or more widespread brushborder damage in
the proximal tubule with basic preservation of cell integrity
[8—10]. On the other hand, all animal models of ischemic ARF,
including those produced by arterial occlusion, intra-arterial
norepinephrine, and glycerol injection, consistently show se-
vere and extensive cell damage both in proximal and distal
tubules [11—16]. Thus, the prominent damage in animal experi-
ments contrasts with the limited damage in human ARF and
may represent an additional injury, not necessarily required for
the development of ARF in human patients. It is not clear
whether this represents a species difference in cellular response
or a difference in the pathophysiological events leading to
injury. During the initiation phase of some of these experimen-
tal models, blood flow through the kidney is severely depressed
[17] or essentially abolished for 45 to 90 mm [14—161, a situation
only infrequently encountered in most cases of clinical ARF
where hypoperfusion, as opposed to cessation of flow, is
recognized as an important etiological feature [18]. It seems,
therefore, that experimental models of ischemia thus far studied
in animals only partially resemble the usual clinical setting for
ARF. It follows that arguments derived from these experiments
as to whether backleak or tubular obstruction is the significant
cause for the depressed glomerular filtration rate (GFR) may
not be directly relevant to an understanding of the human
syndrome.
A second paradox is that in patients with ARF, the most
severe hypoperfusion damage occurs in the best oxygenated
organ. For unclear reasons, the kidney is remarkably suscep-
tible to hypoperfusion, ARF being one of the most frequent
complications of hypotension, shock, or hypovolemia, and
outnumbering by a significant margin the incidence of brain,
myocardial, or liver failure in the same clinical setting [19, 20].
The special susceptibility of the kidneys is even more striking in
view of the disproportionately high blood flow normally en-
joyed by the kidneys in relation to their oxygen consumption
(Table 1) [21—24]. Blood samples from the renal vein have an
oxygen tension considerably higher than the mixed venous
blood draining other organs. The high renal blood flow is
commonly viewed as designed to maximize flow-dependent
clearance of wastes [25], but should also protect the kidney
from potential ischemic insult, by giving it a larger margin of
security than other organs, and making it the least likely organ
to be damaged by compromised blood flow. If, however, the
distribution of blood flow is inhomogeneous, the overall balance
of oxygen supply may conceal severe local tissue hypoxia.
Several studies have demonstrated that oxygen delivery to the
kidney is complex, heterogenous, and gradient-limited, suggest-
ing the possibility of selective regional hypoxia as a potential
major source for localized injury during renal hypoperfusion.
The evidence for this will now be considered.
Heterogeneity of renal oxygenation: significance for the
medullary thick ascending limb of Henle's loop
Gradients of oxygen availability within the renal parenchyma
have been appreciated for some time before the more recent
recognition of their significance. Aukland and Krog [26] were
the first to demonstrate, more than 20 years ago, that medullary
tissue P02 was strikingly lower than arterial P02. Some 10 years
later, Leichtweiss et al [23] and Baumgartl et al [27] confirmed
and extended this idea, demonstrating that the medullary P02
was consistently in the range of 10 mm Hg in the kidney of the
dog and of the rat, both in situ and during isolated perfusion.
Heterogeneity of cortical oxygenation as well was appreciated
in these studies. The cortico-medullary gradient of oxygen has
been ascribed to the organization of vessels in the medullar
which allows countercurrent diffusion of oxygen between the
arterial and venous branches of the vasa recta (Fig. 1). The
demonstration that large variations in respired oxygen concen-
tration hardly affect medullary P02 [27] and the illustration of
a-v shunting within the kidney of oxygen [28, 291 and of krypton
[30] have made the countercurrent exchange of oxygen within
the medulla a plausible and accepted explanation of the low
medullary P02 [21, 31].
Consistent with these findings, the concept of cellular hy-
poxia of the renal medulla has recently been advanced, based
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Table 1. Comparison of balance of oxygen delivery and oxygen
consumption in several organsa
02
Region or
organ
02
delivery
Blood consump-
flow rate tion 02 consumption!
02 delivery
%mlIminIlOO g
Hepato-portal 11.6 58 2.2 18
Kidney 84.0 420 6.8 8
Outer medulla 76b 190b 6.0c 79d
Brain 10.8 54 3.7 34
Skin 2.6 13 0.38 15
Skeletal muscle 0.5 2.7 0.18 34
Heart 16.8 84 11.0 65
aThe table is adapted from [211. Measurements are in humans except for
those from the outer medulla, in which case the estimates are from rats.
bThe blood flow is estimated at 1.9 ml/min/g [22]. The oxygen content
is estimated at 4 vol% (from standard dissociation curves for hemo-
globin) assuming the arterial P02 at 15 to 20mm Hg, highest recordings
of tissue PU2 in this region [23]. The value is probably an overestimate
of the actual oxygen delivery since part of it is lost to the ascending vasa
recta by countercurrent diffusion.
CThis value is probably an underestimate because it is taken from
slices including those from the inner medulla [241.
dThis is a minimum estimate (see b and C)
on direct measurements by optical spectroscopy of the redox
state of cytochrome a,a3, the terminal electron carrier of the
mitochondrial chain which transports electrons directly to
oxygen 132, 33]. Because of its high affinity for oxygen,
cytochrome a,a3 is almost completely oxidized (about 2%
reduction) in relatively well-oxygenated tissues such as resting
muscle [34] or perfused liver [35]. In contrast, Balaban and
Silvia [32] and Epstein, Balaban, and Ross [33] have estimated
the oxidative state of cytochrome a,a3 in rat kidneys as at least
20% reduced in vivo and 30 to 40% reduced during isolated
perfusion, indicating that despite high P02 in the renal artery
and vein, substantial portions of the kidney may exist in a
hypoxic milieu. Because inhibitors of cortical metabolism did
not affect the redox state of the cytochrome, whereas furose-
mide or bumetanide produced a significant oxidation, it ap-
peared that the medullary thick ascending limb of Henle's loop
(mTAL) was an important site of reduced cytochrome oxidase,
so that cells of the mTAL might normally operate on the verge
of anoxia [33].
Selective vulnerability of the mTAL to anoxic injury. During
isolated perfusion of the rat kidney with cell-free albumin-
Ringer's medium, a specific lesion is consistently observed,
occurring within minutes and confined to the mTAL, that
progresses from mitochondrial swelling to nuclear pyknosis and
complete cellular disruption [36—40] (Fig. 2). Of obscure nature
initially [36], this lesion has recently been shown to derive from
selective anoxia in the outer medulla [40]. The lesion involves
half of the mTALs, and is most prominent in those tubules
removed from vascular bundles and near the inner medulla,
areas most likely to be anoxic according to expected gradients
of P02 [23]. Hypoxic perfusion markedly exaggerated the
lesion, and largely removed the gradations of damage, extend-
ing it to all mTALs. Oxygen-enriched perfusions using rat
erythrocytes or hemoglobin prevented the lesion. These find-
ings suggest that the mTAL is exquisitely susceptible to anoxic
damage because of a low oxygen supply imposed by the
medullary countercurrent exchange system and the high rate of
metabolism mandated by active reabsorption of sodium chlo-
ride. The same lesion has been reproduced in vivo, using renal
hypoperfusion in the setting of hypotension secondary to con-
trolled hemorrhage ([41] and unpublished observations) and can
therefore be considered as one of the earliest lesions of renal
ischemia. Interestingly, in the kidneys of hypotensive rats, this
lesion is focal and seems to skip collapsed tubules as if the
absence of tubular reabsorption might be protective (Fig. 2).
Consistent with this notion, mTAL injury associated with
complete arterial occlusion is much less advanced than that of
hypoxia imposed during isolated perfusion (Table 2), as if
abolition of GFR would tend to diminish the severity of the
anoxic damage to the mTAL. The following observations
support this hypothesis.
Cell work for transport accelerates cell injury: transport-
dependent cell death. Inhibition of cell transport activity with
furosemide or ouabain, or by the abolition of glomerular filtra-
tion (using a hyperoncotic non-filtering mode), can protect the
mTAL and consistently prevents injury to the mTAL in the
isolated perfused kidney [39]. Severe and extensive anoxic
mTAL damage produced in this model by perfusion with
cyanide or a hypoxic medium (P02 < 40 mm Hg) is also
remarkably attenuated by reduction of active transport [42].
Furthermore, perfusion with a polyene antibiotic (such as
amphotericin or nystatin) which increases membrane perme-
ability and stimulates the sodium pump, reproduces extensive
anoxic-like injury to the mTAL [43]. This damage is prevented
if active ion transport is inhibited by ouabain [43]. These results
suggest the concept, so familiar to the cardiologist, that oxygen
deficiency is related to its demand. The outer medulla may
exhibit a sort of anginal syndrome in which the degree of
cellular anoxia depends on the demand for oxygen as well as its
supply [44]. This principle has important implications for the
understanding of ischemic mTAL damage, since complete
cessation of blood flow, so frequently used as a model of
ischemic renal injury, necessarily abolishes glomerular filtra-
tion, and thus tends to protect the mTAL and prevent the full
expression of mTAL injury that would have been produced by
hypoperfusion [41]. This is presumably the basis for attenuation
of ischemic injury by furosemide [45] and ouabain [46].
In the perspective of this precarious balance of oxygen
demand and supply in the outer medulla, the reduction of
cortical flow during hypotension [471 may be viewed as de-
signed to prevent medullary ischemia, both directly by increas-
ing oxygen delivery and indirectly by decreasing oxygen de-
mand for solute reabsorption as GFR drops. When this regula-
tory mechanism fails and mTAL ischemia occurs, solute reach-
ing the macula densa will activate tubuloglomerular feedback
[48]. The ensuing profound decrease in GFR might be viewed as
designed to decrease further the needs for solute reabsorption
and oxygen demand in a last-ditch effort to protect the ischemic
mTAL from further damage.
Injury to the mTAL in experimental renal ischemia. Recent
experimental studies have increasingly implicated the mTAL in
ischemic damage. As mentioned above, controlled hemorrhagic
hypotension to an arterial pressure of 30 to 40 mm Hg produces
focal mTAL damage associated with decreased urinary concen-
trating ability before renal failure can be demonstrated [41]. In
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Fig. 1. Heterogeneity of renal oxygenation. A Renal tissue oxygen tension in different parts of the kidney. The upper part illustrates schematically
the renal vascular pattern. (Reprinted with permission from [31]) B Countercurrent exchange of oxygen in the vasa recta: diffusion of oxygen
between arterial and venous limbs minimizes the dissipation of the cortico-medullary gradient of tissue oxygen tension. (Reprinted with permission
from [44])
Fig. 2. Isolated perfused kidney (left); hemorrhagic hypotension (right). These 1-is plastic sections illustrate a portion of the inner stripe of the outer
medulla. This zone contains thick ascending limbs (bars), collecting ducts (C), thin limbs, and vasa recta. Left: After 90 mm of isolated perfusion
the cells of the thick ascending limb show extensive fragmentation. Luminal membranes can no longer be defined; the remaining mitochondria are
swollen and nuclear pyknosis is evident. The lumens of all nephron segments are widely dilated as expected from the high urine output of this
preparation. Right: After 45 mm of hypotension (60 to 80 mm Hg) in vivo extensive luminal collapse is evident, apparently reflecting the cessation
of glomerular filtration in single nephrons. Immediately adjacent to the collecting duct (C), mTALs are present with open lumens (bars); the cells
of these nephron segments show mitochondrial swelling, nuclear pyknosis, and chromatin margination. Such changes are not the simple
consequence of 45-mm ischemia, but probably represent transport-dependent cell injury (see Selective vulnerability of the mTAL to anoxic injury).
In contrast, the epithelium of the collapsed mTALs (arrows) show unremarkable nuclei and mitochondria. Luminal membranes cannot be defined
because of collapse. Small basal vacuoles can be seen (arrows) which represent separation of the basolateral membranes (lateral cellular
interdigitations) as typically seen in nonfiltering nephrons [391. (x 430, >< 430)
the same model, ARF is elicited paradoxically when a lesser cussed above, and might explain why the mTAL lesion was not
degree of hypotension is induced (to <80 mm Hg) for a period seen in one study of severe hypotension in rats [50]. It should be
as short as 15 mm [49]. Too drastic a drop in blood pressure noted, however, that even in models of ischemia using complete
may elicit the protective effect of a decreased GFR, as dis- cessation of blood flow, mTAL damage can be demonstrated,
Core
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Table 2. Comparison of regular perfusion, hypoxic perfusion and complete ischemia in isolated rat kidneys
GFR1
mI/mm
Medullary
tissue P02c
mm Hg
Availability of
exogenous substrate Histology of inner stripe of outer medulla
Regular perfusion
(Cell-free perfusion, 90 mm)
0.6 10—20 Yes Selective damage to the mTAL, advanced and
irreversible in 40% of nephronsa
Hypoxic perfusion
(Cell-free perfusion, 90 mm)
0.1 0—10 Yes Extensive damage to all mTALs
Complete ischemia
(No perfusion, 90 mm)
0 0 No Generalized damage, but much less severe
injury to the mTAL'
aData are from [401.
bData are from [42].
°Data are according to Leichtweiss et al [231.
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Fig. 3. The hypothetical role of the mTAL in the pathophysiology of ischemic ARF. Medullary hypoperfusion is further aggravated by cell swelling
and microvascular damage [59]. mTAL ischemia may produce backleak, obstruction, and activation of tubuloglomerular feedback. If active
transport ceases, the conditions are proper for return to normal structure in mTALs with nonlethal injury ([39—44] and unpublished observations).
Thus, activation of tubuloglomerular feedback or obstruction may reverse or prevent morphologically demonstrable mTAL damage at the expense
of a low GFR. Abbreviations are: S3, pars recta of proximal tubule; mTAL, medullary thick ascending limb of Hente's loop; C, cortex, OM, outer
medulla; OS, outer stripe; IS, inner stripe; IM, inner medulla; U0,,,, urine osmolality; UNa, urinary sodium concentration; SNGFR, single nephron
GFR, K1, glomerular capillary ultrafiltration coefficient.
appearing later than proximal damage [151 but possibly better mia [53, 54]. Data developed by Anderson et a! [55] led them to
correlated with the decrease in renal function [51, 52]. believe that the explanation for polyuria in nonoliguric ARF is
Microperfusion of isolated nephron segments has demonstrated defective solute reabsorption in the mTAL. Recent observa-
dysfunction of the thick ascending limb following renal ische- tions show a selective decrease in the Na-K-ATPase in the
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outer medulla as compared to the cortex during ischemic injury
[56]. Precipitation of Tamm-Horsfall protein, localized uniquely
to the mTAL, and released by damaged and leaking mTAL
cells, may obstruct distal tubules [57, 581. Defective solute
reabsorption in the mTAL will activate tubuloglomerular feed-
back and frank necrosis may also allow backleak. Located at a
strategic site for feedback control of GFR, mTAL injury may
therefore play a central role in the pathogenesis of ARF (Fig. 3).
SignIicance of cortical and medullary hypoperfusion in
ischemic renal injury. Although the studies by Hollenberg et a!
[60, 61] have emphasized cortical hypoperfusion in ARF, other
observations have focused on the impairment in medullary
circulation [59, 62, 63]. Since cortical vasoconstriction persists
in the maintenance phase of nephrotoxic as well as ischemic
ARF [64], it might represent a reactive, adaptive response to
renal insult, rather than a source of injury in itself.' As
suggested earlier, a preferential reduction in cortical flow may
in fact be viewed as a protective mechanism designed to
decrease GFR (and work load for solute reabsorption) and
preserve medullary oxygenation.
Several investigators have emphasized the role of medullary
hypoperfusion and deep nephron damage in the pathogenesis of
ARF [59, 62, 631. Earlier observations described the failure of
blood flow to the kidney after transient ischemia as the no
reflow phenomenon [65—67]. Using colloidal carbon or silicon
rubber injections after renal ischemia, focal no reflow was found
to predominate in the outer medulla and presumed to relate to
microvascular obstruction in this area [68]. Despite the lack of
a completely satisfactory method for accurate quantitation [22],
a reduction of more than 50% in renal medullary blood flow
after ischemic injury has been repeatedly shown with differing
techniques using microspheres [13, 69], hydrogen clearance
[70], or 86rubidium extraction [63, 71, 72]. The mechanisms for
this regional impairment in blood supply are unclear, although
anatomical and functional defects have been invoked:
endothelial damage [68], tubular (S3) swelling [59] (improved by
mannitol), rheological effects [73, 741 (but not reversed by
heparin), release of humoral mediators (such as thromboxanes)
[75], or activation of neural reflexes [76]. The latter might
explain reported improvement in flow and function after renal
ischemia, offered by agents such as clonidine [76, 77],
guanethidine [78], and propranolol [79], or observed after renal
denervation [80]. It is important to appreciate that if nephron
GFR continues while medullary hypoperfusion is present, ei-
ther during the initiation or evolution of ARF, mTAL injury
may result [44]. A failure of the normal autoregulation of
medullary flow [81] could thus have major consequences for the
delicate balance of oxygen demand and supply in the renal
medulla.
Role ofmTAL injury in human renal ischemia. A word should
be said about the difficulties in recognizing selective injury to
the mTAL in human specimens. First, mTAL damage is dif-
ficult to recognize in routinely prepared paraffin sections ([36]
Because the oxygen supply exceeds its rate of consumption in the
renal cortex by about one order of magnitude (Table 1), more than 90%
reduction in cortical blood flow would be required to produce significant
oxygen deprivation. This probably occurs in cortical necrosis or renal
infarction but not in milder forms of ARF.
and unpublished observations). Secondly, in kidney biopsy
specimens, the medulla may not be sampled and even when it is
(usually inadvertently), the structures of the outer medulla are
not easily identified. It is therefore conceivable that in those
studies which have failed to show significantly more damage in
kidneys sampled from patients in ARF as compared to controls,
a discrete, selective and probably focal mTAL lesion has been
overlooked or its significance underestimated [82]. Thirdly,
feedback inhibition of glomerular filtration with marked reduc-
tion in active transport and oxygen demand, may preserve
cellular integrity of the ischemic mTAL but at the cost of renal
failure (Fig. 3).
Some observations have indicated that proximal tubular
damage is worse in S3 (pars recta) as compared to S and S2 [8,
15, 16]. Since S3 is the part of the proximal tubule found in the
outer medulla, this finding fits the concept that the outer
medulla is at a higher risk for anoxic damage than the cortex
[591. In the earliest pathological descriptions of ARF, based on
more than 500 cases, at a time when dialysis was not available
to allow survival after the onset of ARF, Lucké [2] and others
pointed out a "unique and characteristic lesion" of focal
necrosis in the mTAL and distal tubules, hence the term lower
nephron necrosis. This name fell into disfavor after the descrip-
tion by Oliver, MacDowell, and Tracy [8] of patchy focal
necrosis in all segments of the nephron, but the investigators
agreed that these lesions were most frequently seen in the outer
medulla [8]. These fatal cases of ARF were caused by severe
shock associated with profound reductions of renal blood flow,
probably much closer to the animal models of complete renal
ischemia than are cases of hypoperfusion ARF clinically en-
countered today. Later, Sevitt [83] and more recently Solez and
Finckh [841 who re-evaluated older data have shown a correla-
tion between the severity of decrease in renal function and
distal tubular damage in autopsies of patients dying with or
without overt evidence of ARF. Additional clues to distal
nephron injury are infiltration of vasa recta by nucleated cells
and casts in the distal tubules, frequent findings in the human
renal histology of ARF [82]. Isosthenuria [85—88] as well as
increases in the fractional excretion of K [89] and Mg [90],
in the absence of proximal tubular dysfunction (except in heavy
metal toxicity) are also compatible with injury to the mTAL or
inhibition of its transport activity.
We believe that a spectrum of injury, ranging from selective
mTAL ischemia to widespread focal necrosis, may be the
counterpart of the clinical spectrum from mild nonoliguric
forms of ARF after hypoperfusion ischemia to severe oligo-
anuric ARF, seen when blood flow to the kidney has been
severely compromised. At one extreme, the main pathophys-
iological mechanism can be envisioned as flooding the macula
densa by solute not reabsorbed in the mTAL and brisk activa-
tion of tubuloglomerular feedback [48]. At the other extreme,
backleak and tubular obstruction in the mTAL or in other
nephron segments might play major roles in depressing GFR. It
may not, of course, be possible to demonstrate the role of
tubuloglomerular feedback, with angiotensin blockade [91, 921,
renin immunization [93], or partial artery clamping [94] when
other factors override its significance, as in experimental mod-
els of ARF with severe tubular necrosis.
It is remarkable that decreased concentrating ability is not
only the most consistent defect in ARF, more sensitive than low
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fractional excretion of sodium [95] and frequently persisting
after recovery [96], but is also a very early sign of impending
ARF in advanced prerenal azotemia secondary to hypotension
or to a decrease in cardiac output [85—88]. (It may be relevant
that concentrating ability has been shown to be exquisitely
sensitive to brief periods of experimental renal hypoxia induced
by cyanide [97, 98] or mild renal ischemia even in the absence
of acute renal failure [41, 50, 99—103]). It is conceivable that in
progressive prerenal azotemia, when the corticomedullary re-
distribution of blood flow fails to provide enough oxygen to the
outer medulla, mild ischemic damage occurring first in the
mTAL heralds impending mTAL necrosis and activation of
tubuloglomerular feedback (Fig. 3). Even in this setting, rela-
tively preserved distal and collecting tubules may still have the
capacity to reabsorb sodium avidly, producing a low fractional
excretion of sodium in the final urine even when concentrating
ability is abolished. Interestingly, several investigators have
described [104—108] a clinical syndrome of renal hypoperfusion
intermediate between classical prerenal azotemia and estab-
lished ARF, with decreased urine osmolality, polyuria, and a
mild degree of renal insufficiency that is rapidly but not im-
mediately reversed by correction of renal perfusion. These have
been called "partial acute tubular necrosis" [106], "polyuric
prerenal failure" [104], "incipient renal failure" [1071, or "in-
termediate forms" [108] but possibly represent mild forms of
mTAL ischemia. In this setting, therapy with furosemide and/or
fluids with or without mannitol might have prophylactic value
(although, to our knowledge, no controlled study is yet avail-
able to demonstrate this [109]). Furosemide alone will be
detrimental if the ensuing volume depletion is allowed to further
compromise renal perfusion. Treatment should aim at restoring
optimal renal oxygen delivery, by increasing cardiac output
[110, 111], renal vasodilatation [112], and possibly improvement
of the oxygen-carrying capacity of blood.
Unresolved questions
If continued transport activity in mTAL during anoxia can
lead to cell necrosis, one might expect to find defense mecha-
nisms in ischemia, in addition to tubuloglomerular feedback,
designed to reduce reabsorptive work in the mTAL.
Prostaglandin release, for example, would not only promote
medullary vasodilatation but also down-regulate transport ac-
tivity of the mTAL [113], thus preserving its structural integrity
during in vivo ischemia. During isolated kidney perfusion,
blunting of such neurohumoral or paracrine signals might allow
more ready expression of transport-dependent anoxic damage
to the mTAL to be discerned in this model. Interference with
these protective mechanisms in some patients might predispose
to acute renal failure.
Medullary hypoperfusion has yet to be demonstrated in
human ARF. New noninvasive imaging techniques with im-
proved resolution (such as positron scan or nuclear magnetic
resonance) may permit this hypothesis to be tested. Better
quantitation of medullary oxygenation is also required in animal
studies to examine the consequences of different modes of
oxygen deprivation (such as arterial hypoxemia or anemia) on
the effective oxygen supply provided by the vasa recta. For
instance, in the isolated perfused kidney, anemia does not cause
anoxic damage to the mTAL until the oxygen carrying capacity
is below 5 vol%, probably because of reactive vasodilatation
[40]. Experimental variations in arterial P02 over a wide range
cause little or no change in medullary P02, further evidence for
oxygen shunting by countercurrent diffusion [23, 27]. The
effects of anemia or hypoxemia on medullary blood flow and
medullary oxygen delivery, as opposed to total renal blood
flow, have not been established [114—117]. Similarly, the extent
to which anemia or hypoxia predisposes to acute renal failure in
animals or humans is not yet clear. At the extremely low P02
normally present in the medulla, local factors such as pH or
Pco2 may produce important shifts in the hemoglobin-oxygen
dissociation curve that could critically influence cellular oxy-
genation. Finally, while we have emphasized the special vulner-
ability of the renal medulla, and particularly the mTAL, to early
anoxic injury, much work remains to be done to clarify the roles
of medullary versus cortical tubular injury in the initiation and
maintenance of the syndrome of acute renal failure.
In conclusion, because of the precarious balance between
oxygen supply and demand within the outer medulla, the
medullary thick ascending limb, which normally operates on the
verge of anoxia, becomes a prime target for ischemic injury
during renal hypoperfusion, which, we feel, explains the re-
markable vulnerability of the renal parenchyma to ischemia.
Damage to mTALs might activate tubuloglomerular feedback
before significant backleak or tubular obstruction occurs. A
spectrum of injury ranging from mild mTAL ischemia to overt
and generalized tubular necrosis fits the diversity of histology in
ARF and the clinical experience that isosthenuria is the earliest
and the most consistent functional impairment of renal
ischemia.
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